Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Eur J Cancer. 2017 Dec:87:205-208. doi: 10.1016/j.ejca.2017.09.026. Epub 2017 Oct 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Encephalitis / chemically induced*
  • Hashimoto Disease / chemically induced*
  • Humans
  • Lymphoma, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Nivolumab

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Nivolumab

Supplementary concepts

  • Hashimoto's encephalitis